State Street’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-106,487
| Closed | -$9.22K | – | 4571 |
|
|
2023
Q3 | $9.22K | Buy |
106,487
+27,800
| +35% | +$2.41K | ﹤0.01% | 4513 |
|
|
2023
Q2 | $44.1K | Hold |
78,687
| – | – | ﹤0.01% | 4449 |
|
|
2023
Q1 | $89.7K | Hold |
78,687
| – | – | ﹤0.01% | 4350 |
|
|
2022
Q4 | $88.1K | Buy |
78,687
+6,500
| +9% | +$7.28K | ﹤0.01% | 4405 |
|
|
2022
Q3 | $152K | Hold |
72,187
| – | – | ﹤0.01% | 4256 |
|
|
2022
Q2 | $98K | Buy |
72,187
+33,403
| +86% | +$45.3K | ﹤0.01% | 4548 |
|
|
2022
Q1 | $66K | Buy |
38,784
+4,600
| +13% | +$7.83K | ﹤0.01% | 4744 |
|
|
2021
Q4 | $37K | Hold |
34,184
| – | – | ﹤0.01% | 4742 |
|
|
2021
Q3 | $101K | Buy |
34,184
+3,900
| +13% | +$11.5K | ﹤0.01% | 4545 |
|
|
2021
Q2 | $91K | Sell |
30,284
-178,419
| -85% | -$536K | ﹤0.01% | 4378 |
|
|
2021
Q1 | $680K | Sell |
208,703
-12,117
| -5% | -$39.5K | ﹤0.01% | 3695 |
|
|
2020
Q4 | $910K | Buy |
220,820
+4,551
| +2% | +$18.8K | ﹤0.01% | 3569 |
|
|
2020
Q3 | $1.17M | Buy |
216,269
+35,674
| +20% | +$193K | ﹤0.01% | 3397 |
|
|
2020
Q2 | $1.22M | Buy |
180,595
+16,275
| +10% | +$109K | ﹤0.01% | 3363 |
|
|
2020
Q1 | $523K | Buy |
164,320
+19,021
| +13% | +$60.5K | ﹤0.01% | 3439 |
|
|
2019
Q4 | $1.02M | Buy |
145,299
+24,617
| +20% | +$172K | ﹤0.01% | 3403 |
|
|
2019
Q3 | $463K | Sell |
120,682
-1,482
| -1% | -$5.69K | ﹤0.01% | 3520 |
|
|
2019
Q2 | $464K | Buy |
122,164
+15,641
| +15% | +$59.4K | ﹤0.01% | 3523 |
|
|
2019
Q1 | $383K | Buy |
106,523
+86,923
| +443% | +$313K | ﹤0.01% | 3479 |
|
|
2018
Q4 | $152K | Buy |
+19,600
| New | +$152K | ﹤0.01% | 3604 |
|